Ali Salman

Ali Salman

Auto-generated profile, based on publicly available information

Ali Salman

Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in Current Problems in Cardiology
Verified
Journal Article
Closed access
ASAli Salman
Ali Salman
MLMuhammad Omar Larik
Muhammad Omar Larik
MAMuhammad Ali Amir
Muhammad Ali Amir
YMYasir Majeed
Yasir Majeed
MUMaryam Urooj
Maryam Urooj
Jishanth MattumpuramJishanth Mattumpuram
Jishanth Mattumpuram

15 April 2025 in Circulation
Verified
Journal Article
Closed access
JBJaved Butler
Javed Butler
MUMuhammad Shariq Usman
Muhammad Shariq Usman
CGCharu Gandotra
Charu Gandotra
ASAli Salman
Ali Salman
AFAndrew Farb
Andrew Farb
FFFolke Folkvaljon
Folke Folkvaljon
Heart failure is a growing health-care concern affecting tens of millions of individuals globally. Although traditional therapeutic strategies have focused on reducing the risk for hospitalization and mortality, the importance of patient-reported outcomes (PROs) in patients with heart failure is increasingly being recognized. Regulatory agencies consider PROs part of their evaluation of drugs and devices, and professional society guidelines may recommend interventions that improve PROs. However, for several reasons, the effect of interventions on PROs reported in heart failure trials currently is difficult to interpret. There is no consensus on the timing and frequency of PRO assessments. Moreover, it has been difficult to establish a minimal clinically important difference, that is, the minimal change in a PRO score that is meaningful to a patient. In addition, traditional methods of analyzing and reporting PROs such as comparison of mean differences across groups or responder analysis are prone to statistical artifacts and misinterpretation. This article presents an in-depth discussion of these issues, with the Kansas City Cardiomyopathy Questionnaire used as an example, to facilitate the use of PROs in heart failure research, regulatory, and clinical settings.

1 June 2025 in Circulation: Heart Failure
Verified
Journal Article
Closed access
FAFarman Ali
Farman Ali
SAShaaf Ahmad
Shaaf Ahmad
AUAman Ullah
Aman Ullah
ASAli Salman
Ali Salman
ARAdarsh Raja
Adarsh Raja
ANAravinda Nanjundappa
Aravinda Nanjundappa
BACKGROUND: Heart failure (HF) is associated with high mortality rates and substantial health care costs. While there is growing emphasis on integrating palliative care for patients with HF, limited data exist on the locations where adults with HF spend their final days. The study aimed to analyze the location and circumstances of death among adults with HF in the United States using Centers for Disease Control and Prevention’s Wide-ranging Online Data for epidemiological Research data. METHODS: Mortality data from individuals aged ≥20 years, with HF listed as the cause of death between 1999 and 2023, were analyzed. The places of death were categorized as the emergency room, hospice/nursing home, inpatient medical facility, or home. Multinomial logistic regression was performed to examine the associations between demographic factors and death location. RESULTS: HF-related mortality rates declined from 1999 (3.60% and 143.6 age-adjusted mortality rate) to 2010 (3.47% and 123.1 age-adjusted mortality rate). However, rates gradually increased thereafter, reaching 5.18% and 168.1 age-adjusted mortality rate in 2023. Deaths at home nearly doubled, rising from 18.41% (50 648 of 275 132) in 1999 to 33.47% (132 470 of 395 826) in 2023. Hospice/nursing home deaths increased from 30.95% (85 144 of 275 132) in 1999 to 34.71% (116 634 of 336 014) in 2017, but declined to 29.54% (116 931 of 395 826) by 2023. Young adults (20–34 years) had the highest proportion of inpatient deaths. Sex, ethnicity, and urbanization were significant predictors of death location, with men, White individuals, and those in large metropolitan areas more likely to die in medical facilities. CONCLUSIONS: This study underscores the shifting trends in the locations of death among patients with HF, with a ≈2-fold increase in HF-related deaths occurring at home over the past 2 decades. The recent decline in hospice/nursing home deaths, following a period of steady growth, calls for an in-depth examination of contributing barriers. Further research is essential to understand the sociodemographic factors driving disparities in HF-related death locations.

22 September 2025 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ASAli Salman
Ali Salman
AIAreeka Irfan
Areeka Irfan
MSMariam Shahabi
Mariam Shahabi
MSMuteia Shakoor
Muteia Shakoor
MAMohammad Ismail Asim
Mohammad Ismail Asim
AAAhmed Ali Aziz
Ahmed Ali Aziz